Artemis Medicare Q2 FY26 results: PAT up 35% YoY, revenue up 14%

Pat Growth 25pctResults View source PDF Explain this filing

ARTEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+7.3%Reaction day

₹252.50

prior close

₹257.09

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.9%+6.4% vs market

Hospital peers, median of 18sector+0.2%+7.1% vs sector

On the reaction day the stock moved 6.4 pts more than Nifty Microcap 250 and 7.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.2

10m

+3.3

15m

+3.2

30m

+4.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+7.3+0.9+6.4+0.2+7.1

Next day

+7.7+0.8+6.9-0.1+7.8

+6.8+0.7+6.1-0.1+6.9

+8.5+1.3+7.2+0.2+8.3

+11.4+0.5+10.9-0.3+11.7

+14.1+0.4+13.7+0.3+13.8

+10.1-1.5+11.6-0.7+10.8

15d

+7.2-2.4+9.7-3.2+10.5

+11.0-4.4+15.4-2.2+13.1

+3.7-7.2+11.0-7.0+10.7

-3.4-5.0+1.5-8.4+5.0

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 18Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Artemis Medicare reported Q2 FY26 consolidated revenue of Rs 274.7 cr (up 13.8% YoY) and PAT of Rs 30 cr (up 35.6% YoY). H1 FY26 revenue rose 14% to Rs 529.7 cr while PAT jumped 32.5% to Rs 51.2 cr. Standalone results followed similar trends. The board also appointed Mr Prateek Rastogi as new internal auditor replacing Mr Praveen Moon who resigned. Statutory auditor review report was unmodified.

Likely market impact

Strong earnings beat with PAT growing over 35% YoY on healthy revenue growth. Positive signal for shareholders.